CASE STUDY | ANGELINI PHARMA
NEW NEEDS FOR PHARMA INDUSTRY
In the pharmaceutical industry, a deep digitalization process is underway that has prompted organizations to review their business strategies and adopt an increasingly data-oriented approach.
The context in which Angelini Pharma was, before undertaking this project, prevented Digital Managers from evaluating investments in the digital world, and the lack of consolidated data made it difficult to understand the effectiveness of global campaigns and the actual achievement of objectives.
Discover how Blue BI supported Angelini Pharma in the implementation of a Digital Dashboard that, to date, it is used by 86% of enabled users and is the first tool to monitor the performance of multichannel activities and guide strategic business decisions.
The customer's voice
We needed data to understand how investments were going in the digital world. Blue BI has proved to be a reliable partner and has proactively followed us from the early embryonic stages of the project, to design with the country, until its implementation.
Today, the Digital Dashboard is the reference point for the activities of our digital channels and allows us to provide a better service to our HCPs.